AAAAAA
Results:
1-14
|
Results: 14
In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography
Authors:
Aboagye, EO
Price, PM
Jones, T
Citation: Eo. Aboagye et al., In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography, DRUG DISC T, 6(6), 2001, pp. 293-302
Authors:
Brown, GD
Henderson, D
Steel, C
Luthra, S
Price, PM
Brady, F
Citation: Gd. Brown et al., Two routes to [C-11-carbonyl]organo-isocyanates utilizing [C-11]phosgene ([C-11]organo-isocyanates from [C-11]phosgene), NUCL MED BI, 28(8), 2001, pp. 991-998
Authors:
Saleem, A
Harte, RJ
Matthews, JC
Osman, S
Brady, F
Luthra, SK
Brown, GD
Bleehen, N
Conners, T
Jones, T
Price, PM
Aboagye, EO
Citation: A. Saleem et al., Pharmacokinetic evaluation of N-[2(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography, J CL ONCOL, 19(5), 2001, pp. 1421-1429
Authors:
Megyesi, J
Andrade, L
Vieira, JM
Safirstein, RL
Price, PM
Citation: J. Megyesi et al., Positive effect of the induction of p21(WA1/CIP1) on the course of ischemic acute renal failure, KIDNEY INT, 60(6), 2001, pp. 2164-2172
Authors:
Osman, S
Rowlinson-Busza, G
Luthra, SK
Aboagye, EO
Brown, GD
Brady, F
Myers, R
Gamage, SA
Denny, WA
Baguley, BC
Price, PM
Citation: S. Osman et al., Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues, CANCER RES, 61(7), 2001, pp. 2935-2944
Authors:
Aboagye, EO
Saleem, A
Cunningham, VJ
Osman, S
Price, PM
Citation: Eo. Aboagye et al., Extraction of 5-Fluorouracil by tumor and liver: A noninvasive positron emission tomography study of patients with gastrointestinal cancer, CANCER RES, 61(13), 2001, pp. 4937-4941
Authors:
Price, PM
Clark, JH
Macquarrie, DJ
Citation: Pm. Price et al., Modified silicas for clean technology, J CHEM S DA, (2), 2000, pp. 101-110
Authors:
Saleem, A
Aboagye, EO
Price, PM
Citation: A. Saleem et al., In vivo monitoring of drugs using radiotracer techniques, ADV DRUG DE, 41(1), 2000, pp. 21-39
Authors:
Saleem, A
Yap, J
Osman, S
Brady, F
Suttle, B
Lucas, SV
Jones, T
Price, PM
Aboagye, EO
Citation: A. Saleem et al., Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action, LANCET, 355(9221), 2000, pp. 2125-2131
Authors:
Clark, JH
Monks, GL
Nightingale, DJ
Price, PM
White, JF
Citation: Jh. Clark et al., A new solid acid-based route to linear alkylbenzenes, J CATALYSIS, 193(2), 2000, pp. 348-350
Authors:
Brock, CS
Young, H
O'Reilly, SM
Matthews, J
Osman, S
Evans, H
Newlands, ES
Price, PM
Citation: Cs. Brock et al., Early evaluation of tumour metabolic response using [F-18]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas, BR J CANC, 82(3), 2000, pp. 608-615
Authors:
Steel, CJ
Brady, F
Luthra, SK
Brown, G
Khan, I
Poole, KG
Sergis, A
Jones, T
Price, PM
Citation: Cj. Steel et al., An automated radiosynthesis of 2-[C-11]thymidine using anhydrous [C-11]urea derived from[C-11]phosgene, APPL RAD IS, 51(4), 1999, pp. 377-388
Authors:
Harte, RJA
Matthews, JC
O'Reilly, SM
Tilsley, DWO
Osman, S
Brown, G
Luthra, SJ
Brady, F
Jones, T
Price, PM
Citation: Rja. Harte et al., Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa, J CL ONCOL, 17(5), 1999, pp. 1580-1588
Authors:
Megyesi, J
Price, PM
Tamayo, E
Safirstein, RL
Citation: J. Megyesi et al., The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure, P NAS US, 96(19), 1999, pp. 10830-10835
Risultati:
1-14
|